DuPont de Nemours Stock-Based Compensation Growth & History (DD)
DuPont de Nemours's stock-based compensation was $38.0M for fiscal 2025.
View full DuPont de Nemours company overviewDuPont de Nemours annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $38.0M | −$18.0M | −32.14% |
| 2024 | 2024-12-31 | $56.0M | −$1.0M | −1.75% |
| 2023 | 2023-12-31 | $57.0M | −$18.0M | −24.00% |
| 2022 | 2022-12-31 | $75.0M | $8.0M | +11.94% |
| 2021 | 2021-12-31 | $67.0M | −$26.0M | −27.96% |
| 2020 | 2020-12-31 | $93.0M | $6.0M | +6.90% |
| 2019 | 2019-12-31 | $87.0M | −$5.0M | −5.43% |
| 2018 | 2018-12-31 | $92.0M | $73.0M | +384.21% |
| 2017 | 2017-12-31 | $19.0M | −$242.0M | −92.72% |
| 2016 | 2016-12-31 | $261.0M | −$91.0M | −25.85% |
| 2015 | 2015-12-31 | $352.0M | — | — |
DuPont de Nemours quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $14.0M | −$1.0M | −6.67% |
| Q1 2026 | 2026-03-31 | $13.0M | $6.0M | +85.71% |
| Q4 2025 | 2025-12-31 | −$5.0M | — | — |
| Q3 2025 | 2025-09-30 | $21.0M | $5.0M | +31.25% |
| Q2 2025 | 2025-06-30 | $15.0M | −$6.0M | −28.57% |
| Q1 2025 | 2025-03-31 | $7.0M | −$16.0M | −69.57% |
| Q3 2024 | 2024-09-30 | $16.0M | −$6.0M | −27.27% |
| Q2 2024 | 2024-06-30 | $21.0M | $4.0M | +23.53% |
| Q1 2024 | 2024-03-31 | $23.0M | $7.0M | +43.75% |
| Q4 2023 | 2023-12-31 | $2.0M | −$15.0M | −88.24% |
| Q3 2023 | 2023-09-30 | $22.0M | $2.0M | +10.00% |
| Q2 2023 | 2023-06-30 | $17.0M | −$2.0M | −10.53% |
| Q1 2023 | 2023-03-31 | $16.0M | −$3.0M | −15.79% |
| Q4 2022 | 2022-12-31 | $17.0M | −$1.0M | −5.56% |
| Q3 2022 | 2022-09-30 | $20.0M | $5.0M | +33.33% |
| Q2 2022 | 2022-06-30 | $19.0M | $0 | 0.00% |
| Q1 2022 | 2022-03-31 | $19.0M | $4.0M | +26.67% |
| Q4 2021 | 2021-12-31 | $18.0M | $6.0M | +50.00% |
| Q3 2021 | 2021-09-30 | $15.0M | −$6.0M | −28.57% |
| Q2 2021 | 2021-06-30 | $19.0M | −$3.0M | −13.64% |
| Q1 2021 | 2021-03-31 | $15.0M | −$23.0M | −60.53% |
| Q4 2020 | 2020-12-31 | $12.0M | $10.0M | +500.00% |
| Q3 2020 | 2020-09-30 | $21.0M | −$9.0M | −30.00% |
| Q2 2020 | 2020-06-30 | $22.0M | −$12.0M | −35.29% |
| Q1 2020 | 2020-03-31 | $38.0M | $17.0M | +80.95% |
| Q4 2019 | 2019-12-31 | $2.0M | — | — |
| Q3 2019 | 2019-09-30 | $30.0M | $7.0M | +30.43% |
| Q2 2019 | 2019-06-30 | $34.0M | $2.0M | +6.25% |
| Q1 2019 | 2019-03-31 | $21.0M | — | — |
| Q3 2018 | 2018-09-30 | $23.0M | — | — |
| Q2 2018 | 2018-06-30 | $32.0M | — | — |
DuPont de Nemours stock-based compensation trends
Over the last five fiscal years, DuPont de Nemours's stock-based compensation decreased from $93.0M to $38.0M, a change of −$55.0M. The latest reported quarter, Q2 2026, shows $14.0M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review DuPont de Nemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...